Antitumor activity of a novel Aurora A/B kinases inhibitor TY-011 against gastric cancer by inducing DNA damage

被引:1
|
作者
Jiang Tongtong [1 ]
Liu Wang [1 ]
Lu Yu [2 ]
Fang Yanfen [1 ]
Chen Rui [1 ]
Zhang Wanli [1 ]
Liu Xuan [3 ]
Zhang Xiongwen [1 ]
机构
[1] East China Normal Univ, Shanghai Engn Res Ctr Mol Therapeut & New Drug De, Sch Chem & Mol Engn, Shanghai 200062, Peoples R China
[2] Nanjing Tianyi Biosci Co Ltd, Dept Project Management, Nanjing, Peoples R China
[3] Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Integrat Biomed Res, Shanghai, Peoples R China
关键词
apoptosis; Aurora A; B kinases inhibitor; DNA damage; gastric cancer cells; TY-011; B KINASE; APOPTOSIS;
D O I
10.1097/CAD.0000000000000928
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TY-011, a novel Aurora A/B kinases inhibitor, was found in our previous study to exhibit prominent inhibitory effects on growth of gastric cancer, both in vitro and in vivo. To clarify the mechanisms of TY-011 in inhibiting proliferation of gastric cancer cells, the effects of TY-011 on mitosis, cell cycle, apoptosis and cellular DNA were checked in the present study. Our results showed that TY-011 treatment induced aberrant mitosis, G2/M phase arrest and apoptosis. Importantly, TY-011 induced evident DNA damage in MGC-803 and MKN-45 human gastric cancer cells, which was further characterized as DNA double-strand break. Furthermore, cells treated with TY-011 appeared to generate multiple spindle fibers emanating from several spindle poles, leading to poly-merotelic kinetochore. These results suggested that TY-011 induced abnormal microtubule-kinetochores attachment and thus DNA damage, apoptosis and finally inhibition of cell proliferation of human gastric cancer cells.
引用
收藏
页码:440 / 451
页数:12
相关论文
共 50 条
  • [21] Significant in vivo activity of ENMD-2076, a novel inhibitor of Aurora receptor tyrosine kinases, alone and in combination with lenalidomide against plasma cell myeloma
    Sandusky, George E.
    Rodgers, Matt
    Zhang, ShuHong
    Sinn, Anthony
    Pollok, Karen
    Farag, Sherif
    CANCER RESEARCH, 2011, 71
  • [22] Antitumor activity of AMG 900, an orally available small molecule inhibitor of aurora kinases, alone and in combination with tubulin-targeting agents in human metastatic breast cancer
    Bush, Tammy L.
    HeIler, Scott
    Chung, Grace
    Guyot, Deborah
    Kendall, Richard
    Friberg, Greg
    Radinsky, Robert
    Payton, Marc
    CANCER RESEARCH, 2011, 71
  • [23] Nifuratel, a novel STAT3 inhibitor with potent activity against human gastric cancer cells
    Zheng, Hailun
    Hong, Huang
    Zhang, Lulu
    Cai, Xiong
    Hu, Meng
    Cai, Yuepiao
    Zhou, Bin
    Lin, Jiayuh
    Zhao, Chengguang
    Hu, Wanle
    CANCER MANAGEMENT AND RESEARCH, 2017, 9 : 565 - 571
  • [24] Selective anticancer activity of hirsutine against HER2-positive breast cancer cells by inducing DNA damage
    Lou, Chenghua
    Yokoyama, Satoru
    Saiki, Ikuo
    Hayakawa, Yoshihiro
    ONCOLOGY REPORTS, 2015, 33 (04) : 2072 - 2076
  • [25] Riccardin D Exerts Its Antitumor Activity by Inducing DNA Damage in PC-3 Prostate Cancer Cells In Vitro and In Vivo
    Hu, Zhongyi
    Kong, Feng
    Si, Manfei
    Tian, Keli
    Yu, Lin Xi
    Young, Charles Y. F.
    Yuan, Huiqing
    Lou, Hongxiang
    PLOS ONE, 2013, 8 (09):
  • [26] Salvia bowleyanaDunn root is a novel source of salvianolic acid B and displays antitumor effects against gastric cancer cells
    Chen, Binghua
    Huang, Chaoqun
    Zhang, Yuanyan
    Tang, Xiaoqiong
    Li, Suhuan
    Wang, Qingshui
    Lin, Yao
    ONCOLOGY LETTERS, 2020, 20 (01) : 817 - 827
  • [27] AZD1152, an Aurora Kinase B Inhibitor, Sensitizes Prostate Cancer Cells Through Mitotic Arrest and Reduced DNA Damage Repair
    Mitchell, L. R.
    Kopsombut, P.
    Li, J.
    Kim, K.
    Sun, Y.
    Lu, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S569 - S569
  • [28] Antitumor Activity of a Novel Tyrosine Kinase Inhibitor AIU2001 Due to Abrogation of the DNA Damage Repair in Non-Small Cell Lung Cancer Cells
    Ryu, Hwani
    Choi, Hyun-Kyung
    Kim, Hyo Jeong
    Kim, Ah-Young
    Song, Jie-Young
    Hwang, Sang-Gu
    Kim, Jae-Sung
    Kim, Da-Un
    Kim, Eun-Ho
    Kim, Joon
    Ahn, Jiyeon
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (19)
  • [29] Dehydroxymethylepoxyquinomicin, a Novel Nuclear Factor-κB Inhibitor, Enhances Antitumor Activity of Taxanes in Anaplastic Thyroid Cancer Cells
    Meng, Zhaowei
    Mitsutake, Norisato
    Nakashima, Masahiro
    Starenki, Dmytro
    Matsuse, Michiko
    Takakura, Shu
    Namba, Hiroyuki
    Saenko, Vladimir
    Umezawa, Kazuo
    Ohtsuru, Akira
    Yamashita, Shunichi
    ENDOCRINOLOGY, 2008, 149 (11) : 5357 - 5365
  • [30] DCZ5248, a novel dual inhibitor of Hsp90 and autophagy, exerts antitumor activity against colon cancer
    Chen, Xiang-ling
    Liu, Peng
    Zhu, Wei-liang
    Lou, Li-guang
    ACTA PHARMACOLOGICA SINICA, 2021, 42 (01) : 132 - 141